Literature DB >> 499302

Quantitative determination by HPLC of urinary 6beta-hydroxycortisol, an indicator of enzyme induction by rifampicin and antiepileptic drugs.

I Roots, R Holbe, W Hövermann, S Nigam, G Heinemeyer, A G Hildebrandt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 499302     DOI: 10.1007/bf00644969

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  28 in total

1.  ALTERED CORTISOL METABOLISM IN ADVANCED CANCER AND OTHER TERMINAL ILLNESSES: EXCRETION OF 6-HYDROXYCORTISOL.

Authors:  E E WERK; J MACGEE; L J SHOLITON
Journal:  Metabolism       Date:  1964-12       Impact factor: 8.694

2.  6beta-Hydroxycortisol and other polar corticosteroids: measurement and significance in human urine.

Authors:  A G FRANTZ; F H KATZ; J W JAILER
Journal:  J Clin Endocrinol Metab       Date:  1961-10       Impact factor: 5.958

3.  The physiologic significance of 6beta-hydroxycortisol in human corticoid metabolism.

Authors:  F H KATZ; M M LIPMAN; A G FRANTZ; J W JAILER
Journal:  J Clin Endocrinol Metab       Date:  1962-01       Impact factor: 5.958

4.  The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors:  R H SILBER; C C PORTER
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

5.  A study of liquid chromatography in columns. The time of separation.

Authors:  J F Huber; J A Hulsman
Journal:  Anal Chim Acta       Date:  1967 May-Jun       Impact factor: 6.558

6.  The determination of urinary 6-oxygenated cortisol in evaluating liver function.

Authors:  J Chamberlain
Journal:  Clin Chim Acta       Date:  1971-09       Impact factor: 3.786

7.  Effect of intensive occupational exposure to DDT on phenylbutazone and cortisol metabolism in human subjects.

Authors:  A Poland; D Smith; R Kuntzman; M Jacobson; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1970 Sep-Oct       Impact factor: 6.875

8.  Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.

Authors:  S E Smith; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

9.  [Quantitative determination of 6 beta-hydroxycortisol during application of thin layer chromatography with fluorescence indicator].

Authors:  K Berthold; H Staudinger
Journal:  Z Klin Chem Klin Biochem       Date:  1966-05

10.  Changes of the smooth endoplasmic reticulum induced by rifampicin in human and guinea-pig hepatocytes.

Authors:  A M Jezequel; F Orlandi; L T Tenconi
Journal:  Gut       Date:  1971-12       Impact factor: 23.059

View more
  21 in total

Review 1.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

2.  Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects.

Authors:  E Perucca; R Grimaldi; G M Frigo; A Sardi; H Mönig; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

4.  Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man.

Authors:  E E Ohnhaus; A M Breckenridge; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.

Authors:  G Heinemeyer; I Roots; P Lestau; H R Klaiber; R Dennhardt
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

6.  A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.

Authors:  E Perucca; A Hedges; K A Makki; M Ruprah; J F Wilson; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 7.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

Review 8.  Drug interactions with St John's wort : mechanisms and clinical implications.

Authors:  Marcus Mannel
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  Kinetics of hexobarbital and dipyrone in critical care patients receiving high-dose pentobarbital.

Authors:  G Heinemeyer; H J Gramm; W Simgen; R Dennhardt; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 10.  Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives.

Authors:  M Døssing
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.